MedPath

Predictors of Acute and Persistent Postoperative Pain in Lung Cancer Surgery

Active, not recruiting
Conditions
Lung Cancer
Interventions
Diagnostic Test: Preoperative test
Registration Number
NCT05599386
Lead Sponsor
Jannie Bisgaard Stæhr
Brief Summary

The aim of this observational study is to investigate if preoperative quantitative sensory testing, anxiety and depression symptoms, and biological markers are associated with the risk of developing acute and chronic postoperative pain after video-assisted Thoracoscopic surgery (VATS).

Detailed Description

This observational study examine acute and chronic postoperative pain in patients undergoing VATS. In the study preoperative biomarkers, quantitative sensory testing and questionnaires are used to create prediction models for acute and chronic postoperative pain. The study will serve as background information on the risk factors and predictive factors as well as an exploration of the impact of surgical stress from VATS on circulation microRNA and inflammatory mediators.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adults independent of sex with an age of ≥ 18 years
  • Patients scheduled for VATS as a part of either examination or radical treatment of lung cancer
Exclusion Criteria
  • Patients who are unable to understand oral and written information.
  • Patients with known chronic pain in the thorax which have been persisting for at least six months before the day of surgery.
  • Pregnant and nursing women.
  • Patients receiving a planned preoperative epidural blockade during their stay.
  • Patients converted to open surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients Undergoing VATSPreoperative testOnly one group as primary endpoints are continous
Primary Outcome Measures
NameTimeMethod
Numerical Rating Scale365 days postoperative

Pain intensity on a Numerical Rating Scale ranging from 0 indicating no pain to 10 indicating worst pain imaginable at follow up. Collected using the Brief Pain Index

Secondary Outcome Measures
NameTimeMethod
Total equipotent opioid doseTotal equipotent opioid dose in milligrams during the first 48 hours after surgery.

48 hours postoperative

Time to first administration of opioidTime in hours to first postoperative administration of Pro Re Nata (PRN) opioids

48 hours postoperative

Mobilisation48 hours postoperative

Time in hours to full mobilisation defined as walking with or without aids.

Patient-reported satisfaction of postoperative pain management assessed by self-made questionnaire in DanishMeasured twice. Once 48 hours after surgery or at non fixed time(on average 4 days and a maximum of 3 months) as well as at 365 days

Patients are asked to fill out a questionnaire rating their general satisfaction with pain management and sufficiency of pain treatment on a scale from 0 to 10. The questionnaire also assess whether the patients had any perceived side effects and how uncomfortable they were on a scale from 0 to 10.

Trial Locations

Locations (1)

Aalborg University Hospital

🇩🇰

Aalborg, Region Of Northern Jutland, Denmark

© Copyright 2025. All Rights Reserved by MedPath